Sera labs unveils immund₃™ an important new offering to the nutri-strips™ product line; launches new digital e-commerce website to amplify consumer awareness

Los angeles & oxnard, calif.--(business wire)---- $curr #cbd--according to the national institute of health (nih) more than 50 percent of people worldwide have vitamin d insufficiency. in response, sera labs, inc., a wholly owned subsidiary of cure pharmaceutical holdings (otcqb: curr), announced today that it is unveiling “immund₃,” a convenient, science-backed oral thin-film that provides a weekly dose of vitamin d (40,000 iu) as a part of its nutri-strips™ line of novel and innovative vitamins and suppleme
CURR Ratings Summary
CURR Quant Ranking